Atrys Health Reports Treasury Share Transactions Under Liquidity Contract

Atrys Health SA ( (ES:ATRY) ) has provided an update.

Atrys Health has disclosed the activity carried out under its liquidity contract with GVC Gaesco Valores between November 1, 2025 and January 31, 2026, in compliance with Spanish and EU market rules. Over the period, the company executed purchases and sales of its own shares, ending with a higher final share balance of 99,055 securities and a lower cash position of €221,193.60 compared with the period’s initial balance, highlighting its ongoing efforts to provide liquidity and stability in trading of its stock.

The disclosed figures show that Atrys bought 50,457 shares for €146,146.08 at an average price of €2.8964 and sold 44,049 shares for €128,236.16 at an average price of €2.9112, with modest associated expenses. This transparency around treasury share operations under the liquidity contract provides investors with clearer visibility into trading support measures and the company’s management of its own stock in the market.

The most recent analyst rating on (ES:ATRY) stock is a Hold with a EUR3.00 price target. To see the full list of analyst forecasts on Atrys Health SA stock, see the ES:ATRY Stock Forecast page.

More about Atrys Health SA

Atrys Health, S.A. is a Spain-based healthcare company whose shares trade on the Spanish market. The company operates within the medical and health services sector and is subject to Spanish and European securities market regulations, including rules on market abuse and disclosure of transactions in its own shares.

Average Trading Volume: 71,849

Technical Sentiment Signal: Hold

Current Market Cap: €231.7M

See more insights into ATRY stock on TipRanks’ Stock Analysis page.